Peer Review reports
From: DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
| Original Submission | ||
|---|---|---|
| 3 Aug 2022 | Submitted | Original manuscript |
| 5 Sep 2022 | Reviewed | Reviewer Report |
| 5 Sep 2022 | Reviewed | Reviewer Report |
| 27 Sep 2022 | Author responded | Author comments - Shuangshuang Sun |
| 10 Oct 2022 | Reviewed | Reviewer Report |
| 10 Oct 2022 | Reviewed | Reviewer Report |
| 31 Oct 2022 | Author responded | Author comments - Shuangshuang Sun |
| Resubmission - Version 2 | ||
| 27 Sep 2022 | Submitted | Manuscript version 2 |
| 1 Nov 2022 | Author responded | Author comments - Shuangshuang Sun |
| Resubmission - Version 3 | ||
| 1 Nov 2022 | Submitted | Manuscript version 3 |
| 3 Nov 2022 | Author responded | Author comments - Shuangshuang Sun |
| Resubmission - Version 4 | ||
| 3 Nov 2022 | Submitted | Manuscript version 4 |
| 7 Nov 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 14 Nov 2022 | Editorially accepted | |
| 30 Nov 2022 | Article published | 10.1186/s12865-022-00533-0 |
You can find further information about peer review here.